|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.140 EUR | 0.00% |
|
-5.00% | -22.45% |
| Jul. 06 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| Jun. 29 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
| Market Cap | 9.71M 11.04M 9.02M 8.3M 15.56M 1.07B 15.84M 108M 42.09M 522M 41.46M 40.56M 1.81B | P/E 2024 |
30.8x | P/E 2025 | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 10.01M 11.38M 9.3M 8.55M 16.04M 1.1B 16.32M 111M 43.37M 538M 42.72M 41.8M 1.86B | EV / Sales 2024 |
1.79x | EV / Sales 2025 | 1.32x |
| Free-Float |
18.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -5.00% | ||
| Current month | -3.39% | ||
| 3 months | -9.52% | ||
| 6 months | -18.28% | ||
| Current year | -22.45% |
| 1 week | 1.1 |  | 1.18 |
| 1 month | 1.1 | | 1.26 |
| Current year | 1.01 | | 1.6 |
| 1 year | 1.01 | | 1.8 |
| 3 years | 0.88 | | 1.8 |
| 5 years | 0.88 | | 3.3 |
| 10 years | 0.88 | | 3.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 2012-12-31 |
| Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 2012-12-31 |
Flavio Corpina
BRD | Director/Board Member | 47 | 2016-12-31 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/16/25 | Sell | Chief Executive Officer | 968,000 | 10.7556% | ||
| 12/16/25 | Sell | Chief Executive Officer | 322,000 | 3.5778% | ||
| 6/29/22 | Others | Chief Executive Officer | 300,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -5.00% | -11.28% | +16.33% | 11.09M | |
| +2.18% | +1.33% | +48.30% | +157.93% | 1,037B | |
| +0.99% | +3.23% | +52.60% | +50.83% | 615B | |
| +0.91% | +0.63% | +34.34% | +78.79% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.79% | 326B | |
| +1.85% | +3.57% | +37.09% | +40.59% | 293B | |
| -0.11% | +0.48% | +18.87% | +17.70% | 264B | |
| +0.25% | -4.62% | -27.66% | -41.76% | 216B | |
| +0.46% | -1.06% | +18.89% | +56.16% | 198B | |
| -0.47% | -4.67% | +14.42% | +67.32% | 162B | |
| Average | +1.11% | +0.43% | +21.93% | +47.17% | 355.74B | |
| Weighted average by Cap. | +1.55% | +1.47% | +35.07% | +75.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.03M 6.86M 5.6M 5.15M 9.67M 664M 9.84M 67.01M 26.14M 324M 25.75M 25.19M 1.12B | 9.73M 11.06M 9.04M 8.31M 15.59M 1.07B 15.87M 108M 42.17M 523M 41.54M 40.64M 1.81B |
| Net income | 353K 401K 328K 301K 565K 38.85M 575K 3.92M 1.53M 18.95M 1.51M 1.47M 65.74M | 737K 838K 685K 630K 1.18M 81.15M 1.2M 8.19M 3.19M 39.58M 3.15M 3.08M 137M |
| Net Debt | 5.77K 6.56K 5.36K 4.93K 9.24K 635K 9.41K 64.07K 24.99K 310K 24.62K 24.08K 1.07M | 295K 336K 274K 252K 473K 32.53M 482K 3.28M 1.28M 15.87M 1.26M 1.23M 55.04M |
Employees
50
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | €1.140 | 0.00% | 0 |
| 26-07-22 | €1.140 | -0.87% | 25,000 |
| 26-07-21 | €1.150 | -0.86% | 2,000 |
| 26-07-20 | €1.160 | -1.69% | 9,000 |
| 26-07-17 | €1.180 | -1.67% | 9,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
Select your edition
All financial news and data tailored to specific country editions
